Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+75.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $14.67M | +33.8% |
| 2024 | $10.96M | +43.6% |
| 2023 | $7.63M | +182.7% |
| 2022 | $2.70M | - |